UBA7
protein-codingubiquitin like modifier activating enzyme 7, the group of Ubiquitin like modifier activating enzymes|MicroRNA protein coding host genes
Gene summary
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E1 ubiquitin-activating enzyme family. The encoded enzyme is a retinoid target that triggers promyelocytic leukemia (PML)/retinoic acid receptor alpha (RARalpha) degradation and apoptosis in acute promyelocytic leukemia, where it is involved in the conjugation of the ubiquitin-like interferon-stimulated gene 15 protein. [provided by RefSeq, Jul 2008]
- UBE1L
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~8.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to UBA7 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_003335.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 5 | 2 | 10 | ||
| missense | 148 | 14 | 2 | 164 | ||
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 5 | 5 | ||||
| Total | 0 | 0 | 159 | 19 | 4 | 182 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_003326.2 | 24 | MANE Select | |
| Ensembl | ENSP00000333266.3 | 24 | MANE Select | |
| Ensembl | ENSP00000575657.1 | 23 | Standard | |
| Ensembl | ENSP00000575657.1 | 23 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Ubiquitin mediated proteolysis - Homo sapiens (human)
- Parkinson,s disease - Homo sapiens (human)
- Proteasome Degradation
- Parkinsons Disease Pathway
- DNA Repair
Biological Process
- cellular protein modification process
- cellular response to DNA damage stimulus
- protein ubiquitination
- modification-dependent protein catabolic process
- ISG15-protein conjugation
Molecular Function
- ubiquitin-protein transferase activity
- protein binding
- ATP binding
- ISG15 activating enzyme activity
Cellular Component
- nucleus
- nucleoplasm
- cytoplasm
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000333486
- Coding exons
- 24
- Length
- 8740
- Individuals with no LoFs
- 125314
- Homozygous LoFs
- 4
- Heterozygous LoFs
- 430
- Defined
- 125748
- p
- 0.00173
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.988 | 507 | 574 | 0.884 | 0.0000328 | 6504 |
| Missense (PolyPhen) | 130 | 174.05 | 0.74692 | 2179 | ||
| Synonymous | 0.308 | 232 | 238 | 0.975 | 0.0000133 | 2131 |
| Loss of Function | 2.18 | 34 | 50.8 | 0.670 | 0.00000246 | 570 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0015 | 0.0015 | notable |
| Latino/Admixed American | 0.0017 | 0.0017 | notable |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.00050 | 0.00049 | rare |
| Finnish | 0.00014 | 0.00014 | rare |
| European (Non-Finnish) | 0.0013 | 0.0012 | notable |
| South Asian | 0.0060 | 0.0058 | notable |
| Other | 0.0031 | 0.0031 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Activates ubiquitin by first adenylating with ATP its C- terminal glycine residue and thereafter linking this residue to the side chain of a cysteine residue in E1, yielding a ubiquitin- E1 thioester and free AMP. Catalyzes the ISGylation of influenza A virus NS1 protein. {ECO:0000269|PubMed:16254333, ECO:0000269|PubMed:20133869}.;
Recessive Scores
- pRec
- 0.145
Intolerance Scores
- LoFtool
- 0.935
- RVIS EVS
- 0.25
- RVIS percentile EVS
- 69.66
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.235
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |